Cleared Traditional

K113764 - GLUCOSE METER-CHECK SOLUTION FOR INFOPIA

K113764 is the FDA 510(k) clearance for GLUCOSE METER-CHECK SOLUTION FOR INFOPIA by Bionostics, Inc.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 40-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2012
Decision
40d
Days
Class 1
Risk

K113764 is an FDA 510(k) clearance for the GLUCOSE METER-CHECK SOLUTION FOR INFOPIA. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bionostics, Inc. (Devens, US). The FDA issued a Cleared decision on January 30, 2012 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bionostics, Inc. devices

Submission Details

510(k) Number K113764 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2011
Decision Date January 30, 2012
Days to Decision 40 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 88d · This submission: 40d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 274
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K113764.
ELECSYS LH CALCHECK 5
K121279 · Roche Diagnostics · May 2012
LOCI CARDIAC TROPONIN-I CONTROL (LOW), LCTNI CON L
K121084 · Siemens Healthcare Diagnostics, Inc. · May 2012
ON CALL VIVID BLOOD GLUCOSE MONITORING SYSTEMS
K112653 · ACON Laboratories, Inc. · Apr 2012
ACCESS HYBRITECH P2PSA QC ON THE ACCESS IMMUNOASSAY SYSTEMS
K112603 · Beckman Coulter, Inc. · Nov 2011
CVM, UNCONJUGATED ESTRIOL (UE3) CALIBRATION VERIFICATION MATERIAL
K110061 · Siemens Healthcare Diagnostics · Sep 2011
ELECSYS MYOGLOBIN CALCHECK 5
K112113 · Roche Diagnostics · Sep 2011